Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-23

Clinical Trial Update: Role of Oxytocin in Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/Phase 3 clinical trial evaluating the role of oxytocin in myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Myocardial Infarction | Phase 2, Phase 3 | Status: UNKNOWN